Xingyu Liu, Lubna Rahman, Yang Zhang, Rui Guo, Min Zhang, Wei Zhou
{"title":"Identification of antifungal metabolites from a soil-derived Streptomyces strain active against Fusarium graminearum using genome mining.","authors":"Xingyu Liu, Lubna Rahman, Yang Zhang, Rui Guo, Min Zhang, Wei Zhou","doi":"10.1007/s10529-025-03605-4","DOIUrl":null,"url":null,"abstract":"<p><p>Microbes derived from soil environments are well-recognized as prolific producers of bioactive secondary metabolites, making significant contributions to the advancement of antibiotic research. In this study, we isolated a soil-derived Streptomyces strain, designated Streptomyces sp. AHU1, which exhibited potent antifungal activity against Fusarium graminearum, the primary causative agent of Fusarium head blight. The potential of Streptomyces sp. AHU1 as a novel phytopathogenic fungicide was validated through in vitro antifungal assays and infection bioassays conducted on wheat seedlings. Whole genome sequencing combined with anti-SMASH genome mining identified approximately 34 biosynthetic gene clusters (BGCs) within the genome of Streptomyces sp. AHU1. Targeted isolation and functional analysis of these BGCs revealed that the antifungal activity is primarily attributed to lucensomycin, a previously characterized antifungal compound. This study underscores the potential of Streptomyces sp. AHU1 as a promising agent for sustainable crop protection and highlights the effectiveness of integrating bioassay-based screening with genome mining for BGC characterization as a robust strategy for the discovery of novel phytopathogenic fungicides.</p>","PeriodicalId":8929,"journal":{"name":"Biotechnology Letters","volume":"47 3","pages":"61"},"PeriodicalIF":2.1000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Letters","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s10529-025-03605-4","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Microbes derived from soil environments are well-recognized as prolific producers of bioactive secondary metabolites, making significant contributions to the advancement of antibiotic research. In this study, we isolated a soil-derived Streptomyces strain, designated Streptomyces sp. AHU1, which exhibited potent antifungal activity against Fusarium graminearum, the primary causative agent of Fusarium head blight. The potential of Streptomyces sp. AHU1 as a novel phytopathogenic fungicide was validated through in vitro antifungal assays and infection bioassays conducted on wheat seedlings. Whole genome sequencing combined with anti-SMASH genome mining identified approximately 34 biosynthetic gene clusters (BGCs) within the genome of Streptomyces sp. AHU1. Targeted isolation and functional analysis of these BGCs revealed that the antifungal activity is primarily attributed to lucensomycin, a previously characterized antifungal compound. This study underscores the potential of Streptomyces sp. AHU1 as a promising agent for sustainable crop protection and highlights the effectiveness of integrating bioassay-based screening with genome mining for BGC characterization as a robust strategy for the discovery of novel phytopathogenic fungicides.
期刊介绍:
Biotechnology Letters is the world’s leading rapid-publication primary journal dedicated to biotechnology as a whole – that is to topics relating to actual or potential applications of biological reactions affected by microbial, plant or animal cells and biocatalysts derived from them.
All relevant aspects of molecular biology, genetics and cell biochemistry, of process and reactor design, of pre- and post-treatment steps, and of manufacturing or service operations are therefore included.
Contributions from industrial and academic laboratories are equally welcome. We also welcome contributions covering biotechnological aspects of regenerative medicine and biomaterials and also cancer biotechnology. Criteria for the acceptance of papers relate to our aim of publishing useful and informative results that will be of value to other workers in related fields.
The emphasis is very much on novelty and immediacy in order to justify rapid publication of authors’ results. It should be noted, however, that we do not normally publish papers (but this is not absolute) that deal with unidentified consortia of microorganisms (e.g. as in activated sludge) as these results may not be easily reproducible in other laboratories.
Papers describing the isolation and identification of microorganisms are not regarded as appropriate but such information can be appended as supporting information to a paper. Papers dealing with simple process development are usually considered to lack sufficient novelty or interest to warrant publication.